EG18144A - Heterocyclic oxphtalazinyl acetic acids - Google Patents

Heterocyclic oxphtalazinyl acetic acids

Info

Publication number
EG18144A
EG18144A EG690/86A EG69086A EG18144A EG 18144 A EG18144 A EG 18144A EG 690/86 A EG690/86 A EG 690/86A EG 69086 A EG69086 A EG 69086A EG 18144 A EG18144 A EG 18144A
Authority
EG
Egypt
Prior art keywords
oxphtalazinyl
heterocyclic
acetic acids
acetic
acids
Prior art date
Application number
EG690/86A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/796,359 external-priority patent/US4723010A/en
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG18144A publication Critical patent/EG18144A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EG690/86A 1985-11-07 1986-11-06 Heterocyclic oxphtalazinyl acetic acids EG18144A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79603985A 1985-11-07 1985-11-07
US06/796,359 US4723010A (en) 1985-11-07 1985-11-07 Process for preparing chloromethyl thiazoles or oxazoles, and intermediates for use therein

Publications (1)

Publication Number Publication Date
EG18144A true EG18144A (en) 1992-08-30

Family

ID=27121684

Family Applications (1)

Application Number Title Priority Date Filing Date
EG690/86A EG18144A (en) 1985-11-07 1986-11-06 Heterocyclic oxphtalazinyl acetic acids

Country Status (18)

Country Link
EP (1) EP0222576B1 (zh)
KR (1) KR890002758B1 (zh)
CN (1) CN1009831B (zh)
AU (1) AU574589B2 (zh)
DE (1) DE3684410D1 (zh)
DK (1) DK172010B1 (zh)
EG (1) EG18144A (zh)
ES (1) ES2032749T3 (zh)
FI (1) FI87355C (zh)
GR (1) GR3004099T3 (zh)
IE (1) IE59315B1 (zh)
IL (1) IL80475A (zh)
NO (1) NO168303C (zh)
NZ (1) NZ218192A (zh)
PL (1) PL151024B1 (zh)
PT (1) PT83684B (zh)
SU (1) SU1551246A3 (zh)
YU (1) YU45027B (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
IL87709A (en) * 1987-09-16 1992-11-15 Pfizer Process for preparing haloalkyl thiazoles and some such novel haloalkyl thiazoles
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4940791A (en) * 1988-02-29 1990-07-10 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel hydrazine containing intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
US5304557A (en) * 1989-12-15 1994-04-19 Pfizer Inc. Substituted oxoophthalazinyl acetic acids and analogs thereof
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5037831A (en) * 1990-05-21 1991-08-06 American Home Products Corporation Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
JPH04217684A (ja) * 1990-05-30 1992-08-07 Shionogi & Co Ltd アルド−ス還元酵素阻害物質
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
ES2158897T3 (es) 1993-06-23 2001-09-16 Diatide Inc Peptidos radiomarcados derivados de somatostatina y utilizados en procedimientos de formacion de imagenes y terapeuticos.
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
YU59600A (sh) 1998-03-31 2002-12-10 The Institute For Pharmaceutical Discovery Inc. Supstituisane indolalkanoidske kiseline
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
US6570013B2 (en) 2000-02-16 2003-05-27 Pfizer Inc Salts of zopolrestat
WO2002098429A1 (en) * 2001-06-07 2002-12-12 Pfizer Products Inc. Ethanolamine, diethanolamine or triethanolamine salt of zopolrestat
DE10225750A1 (de) 2002-06-10 2003-12-18 Degussa Verfahren zur Herstellung von 2-Chloro-1,1,1-trialkoxyethan
CN101058558B (zh) * 2007-05-28 2013-04-10 沈阳药科大学 具有醛糖还原酶抑制活性的4-氧代-1(4h)-喹啉羧酸类化合物、组合物及其制备方法
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
EP3192796B1 (en) * 2010-07-16 2019-09-04 The Trustees of Columbia University in the City of New York Aldose reductase inhibitors and uses thereof
SI3352754T1 (sl) 2016-06-21 2021-03-31 The Trustees Of Columbia University In The City Of New York Zaviralci aldozne reduktaze in postopki njihove uporabe
CA3071114A1 (en) 2017-07-28 2019-01-31 Applied Therapeutics Inc. Compositions and methods for treating galactosemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture

Also Published As

Publication number Publication date
KR890002758B1 (ko) 1989-07-27
NO168303C (no) 1992-02-05
DK529886D0 (da) 1986-11-06
AU574589B2 (en) 1988-07-07
IE862923L (en) 1987-05-07
YU189086A (en) 1988-06-30
DE3684410D1 (de) 1992-04-23
EP0222576B1 (en) 1992-03-18
FI864512A0 (fi) 1986-11-06
GR3004099T3 (zh) 1993-03-31
NZ218192A (en) 1989-08-29
IL80475A (en) 1993-01-31
FI87355B (fi) 1992-09-15
DK172010B1 (da) 1997-09-15
EP0222576A3 (en) 1988-03-23
IE59315B1 (en) 1994-02-09
CN86108308A (zh) 1987-07-15
PT83684B (pt) 1989-06-30
PL151024B1 (en) 1990-07-31
FI87355C (fi) 1992-12-28
CN1009831B (zh) 1990-10-03
KR870004981A (ko) 1987-06-02
ES2032749T3 (es) 1993-03-01
PT83684A (en) 1986-12-01
YU45027B (en) 1991-06-30
AU6485886A (en) 1987-06-11
NO864425L (no) 1987-05-08
SU1551246A3 (ru) 1990-03-15
DK529886A (da) 1987-05-08
FI864512A (fi) 1987-05-08
EP0222576A2 (en) 1987-05-20
NO864425D0 (no) 1986-11-06
NO168303B (no) 1991-10-28
PL262266A1 (en) 1987-11-30

Similar Documents

Publication Publication Date Title
EG18144A (en) Heterocyclic oxphtalazinyl acetic acids
PH22790A (en) Thiazolidine carboxylic acid derivatives
GB8503424D0 (en) Heterocyclic derivatives
EP0252880A3 (en) Hydroxyphosphono carboxylic acids
GB8607855D0 (en) Carboxylic acid ester derivatives
ZA889519B (en) Heterocyclic oxophthalazinyl acetic acids
GB8509641D0 (en) Carboxylic di-esters/acids
GB2176784B (en) 3-acylamino-2-oxo-1-azetidinesulfonic acids
ZA868450B (en) Heterocyclic oxophtalazinyl acetic acids
GB8630759D0 (en) Carboxylic acid derivatives
GB8417314D0 (en) Carboxylic acid derivatives
GB8709794D0 (en) Heterocyclic acids
GB8727048D0 (en) Acetic acid
GB8604686D0 (en) Carboxylic acids
GB2181127B (en) 4-phenyl-dihydropyridine carboxylic acid derivatives
IL79770A0 (en) Cyclohexanealkanoic acids
DE3666950D1 (en) P-hydroxybenzoic acid derivatives
GB8511897D0 (en) Carboxylic acids
IE850795L (en) Substituted ó-amino acids
GB8401749D0 (en) Heterocyclic acids
GB8431967D0 (en) Heterocyclic acids
IE851538L (en) Indole - 2 - alkanoic acids
IE850609L (en) Methyleneaminophenylalkane-carboxylic acids
GB8624988D0 (en) Carboxylic acids
GB8503158D0 (en) Heterocyclic carboxylic esters